Gero raises $6M to hack the ageing code and combat age-related diseases
Longevity Technology - 18-Oct-2023Company's quest to decode ageing and develop novel therapies gains momentum
Join the club for FREE to access the whole archive and other member benefits.
AI-powered platform for drug discovery and drug repurposing for age-related diseases.
Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues. We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.
Visit website: https://gero.ai/
Details last updated 03-Feb-2020
Digital biomarker for biological age and resilience to assess lifestyle, nutraceutical and therapeutic interventions
Company's quest to decode ageing and develop novel therapies gains momentum
Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years
Some really exciting developments with quite a few in clinical trials
Tracks biological age from physical activity without requiring a blood test
Enhancement of bactericidal effect at the same antibiotic dose
Is it time to find ways to make it our average life expectancy?
A natural limit of 120-150 is a good start before even starting rejuvenation therapies
With whole exome and genome sequencing we could reveal so many secrets of life
When some of these succeed in human trials even more money will pile in to fund further advances
Physical activity data from wearables can produce digital biomarkers of aging. AI-based algorith...
Strehler-Mildvan (SM) correlation was reported in 1960. It relates to the Mortality Rate Doublin...